Related Experiment Video
Updated: Aug 20, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern
Hitesh Dighe1, Prasad Sarkale1, Deepak Y Patil1
1Indian Council of Medical Research-National Institute of Virology, Pune 411021, Maharashtra, India.
Abstract:
The unique mutations of the SARS-CoV-2 Omicron variant are associated with increased transmissibility, immune escape, increased binding affinity to ACE-2, and increased viral load. Omicron exhibited a shift in tropism infecting the upper respiratory tract compared to other variants of concern which have tropism for the lower respiratory tract. The tropism of omicron variants in cell lines of different hosts and tissue origins still remains unclear. Considering this, we assessed the susceptibility of different cell lines to the SARS-CoV-2 omicron BA.1.1 variant and permissiveness among different cell lines for omicron replication. Susceptibility and permissiveness of a total of eleven cell lines, including six animal cell lines and five human cell lines for omicron BA.1.1 infection, were evaluated by infecting individual cell lines with omicron BA.1.1 isolate at a 0.1 multiplicity of infection. Virus replication was assessed by observation of cytopathic effects followed by viral load determination by real-time PCR assay and virus infectivity determination by TCID50 assay. The characteristic cytopathic effect, increased viral load, and productive omicron replication was detected in Vero CCL-81, Vero E6, Vero/hSLAM, MA-104, and Calu-3 cells. Although LLC MK-2 cells showed an increased TCID50 titer at the second infection, the viral load did not show much difference in both infections. Caco-2 cells did not show evident CPE, but they supported omicron replication at a low level. A549, RD, MRC-5, and BHK-21 cells supported omicron BA.1.1 replication without the CPE. This is the first study on the comparison of susceptibility of different cell lines to Omicron variant BA.1.1, which might be useful for future studies on emerging SARS-CoV-2 variants.
Insights
This study evaluated the susceptibility of eleven cell lines to the SARS-CoV-2 Omicron BA.1.1 variant. Vero, MA-104, and Calu-3 cells showed productive Omicron replication, aiding future variant research.
Area of Science:
- Virology
- Cell Biology
- Infectious Diseases
Background:
- The SARS-CoV-2 Omicron variant exhibits increased transmissibility and immune escape.
- Omicron BA.1.1 shows a tropism shift towards the upper respiratory tract.
- The tropism and replication permissiveness of Omicron in various cell lines remain unclear.
Purpose of the Study:
- To assess the susceptibility of diverse cell lines to the SARS-CoV-2 Omicron BA.1.1 variant.
- To determine the permissiveness of different host cell lines for Omicron replication.
- To provide insights for future research on emerging SARS-CoV-2 variants.
Main Methods:
- Eleven cell lines (six animal, five human) were infected with Omicron BA.1.1 at a 0.1 multiplicity of infection.
- Virus replication was assessed via cytopathic effects (CPE), viral load (real-time PCR), and infectivity (TCID50 assay).
Main Results:
- Productive Omicron BA.1.1 replication with characteristic CPE and increased viral load was observed in Vero CCL-81, Vero E6, Vero/hSLAM, MA-104, and Calu-3 cells.
- LLC-MK2 cells showed increased infectivity but not viral load. Caco-2 cells supported low-level replication without evident CPE.
- A549, RD, MRC-5, and BHK-21 cells supported Omicron BA.1.1 replication without observable CPE.
Conclusions:
- This study provides the first comparative analysis of Omicron BA.1.1 susceptibility across multiple cell lines.
- Specific cell lines like Vero, MA-104, and Calu-3 are highly permissive to Omicron BA.1.1.
- Findings are crucial for selecting appropriate models in future SARS-CoV-2 variant studies.
More Related Videos
Related Concept Videos
Cell Lines
Single Nucleotide Polymorphisms-SNPs

